The FDA approved a once-weekly combined hormonal contraceptive patch with low-dose estrogen for women who could become pregnant and have a BMI of less than 30 kg/m2, according to an industry press release.
Gwyn Lo (Viatris Inc.) is a transdermal patch applied once weekly for 3 consecutive weeks, followed by 1 week without the patch. The transdermal system delivers 220 mcg per day of norelgestromin and 20 mcg per day of ethinyl estradiol each week.
The system received FDA approval based on findings from the phase 3 Luminous study. The study enrolled postmenarcheal women aged 18 to 35 years with

A Meriden woman faces attempted child trafficking charges after two juveniles were found in a hotel room, highlighting the lasting trauma of exploitation.

A Nature Medicine study of 2.5 million adults found 26 genetic regions linked to fibromyalgia and pointed to nervous system pathways.

Colorado reported over 250 Salmonella cases in July, more than 100 above average. No source has been identified.

UK regulators reviewed 17 studies on bladder anticholinergics and dementia. The evidence could not confirm or exclude a causal link.

FDA advisers review Replimune's melanoma therapy Thursday. The agency's own briefing documents question the interpretability of the trial data.

Lolo Jones revealed a spinal fracture after testing a new bobsled, reinforcing the need for urgent evaluation of spinal injuries and neurological symptoms.

An Idaho air quality advisory covers Butte, Custer and Lemhi counties. What people with asthma, COPD or heart disease should do.

A worker died in a suspected Wisconsin lightning strike. What the 30-minute rule means and why victims are safe to touch.

Extreme heat warnings cover most of Florida, with heat indices reaching 115. What caregivers of seniors and young children should do now.